Cite
MLA Citation
R. Young et al.. “3434 A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma.” European journal of cancer, vol. 51, n.d., pp. S699–. http://access.bl.uk/ark:/81055/vdc_100030687863.0x000020